These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Antibody Responses to BNT162b2 Vaccination in Japan: Monitoring Vaccine Efficacy by Measuring IgG Antibodies against the Receptor-Binding Domain of SARS-CoV-2. Fujigaki H; Yamamoto Y; Koseki T; Banno S; Ando T; Ito H; Fujita T; Naruse H; Hata T; Moriyama S; Takahashi Y; Suzuki T; Murakami T; Yoshida Y; Yagura Y; Oyamada T; Takemura M; Kondo M; Iwata M; Saito K Microbiol Spectr; 2022 Feb; 10(1):e0118121. PubMed ID: 35044205 [TBL] [Abstract][Full Text] [Related]
43. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19. Li K; Huang B; Wu M; Zhong A; Li L; Cai Y; Wang Z; Wu L; Zhu M; Li J; Wang Z; Wu W; Li W; Bosco B; Gan Z; Qiao Q; Wu J; Wang Q; Wang S; Xia X Nat Commun; 2020 Nov; 11(1):6044. PubMed ID: 33247152 [TBL] [Abstract][Full Text] [Related]
44. Saliva SARS-CoV-2 Antibody Prevalence in Children. Keuning MW; Grobben M; de Groen AC; Berman-de Jong EP; Bijlsma MW; Cohen S; Felderhof M; de Groof F; Molanus D; Oeij N; Rijpert M; van Eijk HWM; Koen G; van der Straten K; Oomen M; Visser R; Linty F; Steenhuis M; Vidarsson G; Rispens T; Plötz FB; van Gils MJ; Pajkrt D Microbiol Spectr; 2021 Oct; 9(2):e0073121. PubMed ID: 34523985 [TBL] [Abstract][Full Text] [Related]
46. Pediatric evaluation of clinical specificity and sensitivity of SARS-CoV-2 IgG and IgM serology assays. Bohn MK; Hall A; Wilson S; Taher J; Sepiashvili L; Adeli K Clin Chem Lab Med; 2021 May; 59(6):e235-e237. PubMed ID: 33577725 [No Abstract] [Full Text] [Related]
47. Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients. Isho B; Abe KT; Zuo M; Jamal AJ; Rathod B; Wang JH; Li Z; Chao G; Rojas OL; Bang YM; Pu A; Christie-Holmes N; Gervais C; Ceccarelli D; Samavarchi-Tehrani P; Guvenc F; Budylowski P; Li A; Paterson A; Yue FY; Marin LM; Caldwell L; Wrana JL; Colwill K; Sicheri F; Mubareka S; Gray-Owen SD; Drews SJ; Siqueira WL; Barrios-Rodiles M; Ostrowski M; Rini JM; Durocher Y; McGeer AJ; Gommerman JL; Gingras AC Sci Immunol; 2020 Oct; 5(52):. PubMed ID: 33033173 [TBL] [Abstract][Full Text] [Related]
48. Biodistribution and serologic response in SARS-CoV-2 induced ARDS: A cohort study. Schlesinger T; Weißbrich B; Wedekink F; Notz Q; Herrmann J; Krone M; Sitter M; Schmid B; Kredel M; Stumpner J; Dölken L; Wischhusen J; Kranke P; Meybohm P; Lotz C PLoS One; 2020; 15(11):e0242917. PubMed ID: 33232382 [TBL] [Abstract][Full Text] [Related]
49. Immune responses to SARS-CoV-2 in three children of parents with symptomatic COVID-19. Tosif S; Neeland MR; Sutton P; Licciardi PV; Sarkar S; Selva KJ; Do LAH; Donato C; Quan Toh Z; Higgins R; Van de Sandt C; Lemke MM; Lee CY; Shoffner SK; Flanagan KL; Arnold KB; Mordant FL; Mulholland K; Bines J; Dohle K; Pellicci DG; Curtis N; McNab S; Steer A; Saffery R; Subbarao K; Chung AW; Kedzierska K; Burgner DP; Crawford NW Nat Commun; 2020 Nov; 11(1):5703. PubMed ID: 33177504 [TBL] [Abstract][Full Text] [Related]
50. Cross-reactive antibodies after SARS-CoV-2 infection and vaccination. Grobben M; van der Straten K; Brouwer PJ; Brinkkemper M; Maisonnasse P; Dereuddre-Bosquet N; Appelman B; Lavell AA; van Vught LA; Burger JA; Poniman M; Oomen M; Eggink D; Bijl TP; van Willigen HD; Wynberg E; Verkaik BJ; Figaroa OJ; de Vries PJ; Boertien TM; ; Bomers MK; Sikkens JJ; Le Grand R; de Jong MD; Prins M; Chung AW; de Bree GJ; Sanders RW; van Gils MJ Elife; 2021 Nov; 10():. PubMed ID: 34812143 [TBL] [Abstract][Full Text] [Related]
51. Over 1-year duration and age difference of SARS-CoV-2 antibodies in convalescent COVID-19 patients. Zeng F; Wu M; Wang J; Li J; Hu G; Wang L J Med Virol; 2021 Dec; 93(12):6506-6511. PubMed ID: 34170519 [TBL] [Abstract][Full Text] [Related]
52. Coronavirus Pseudotypes for All Circulating Human Coronaviruses for Quantification of Cross-Neutralizing Antibody Responses. Sampson AT; Heeney J; Cantoni D; Ferrari M; Sans MS; George C; Di Genova C; Mayora Neto M; Einhauser S; Asbach B; Wagner R; Baxendale H; Temperton N; Carnell G Viruses; 2021 Aug; 13(8):. PubMed ID: 34452443 [TBL] [Abstract][Full Text] [Related]
53. Human IgG and IgA responses to COVID-19 mRNA vaccines. Wisnewski AV; Campillo Luna J; Redlich CA PLoS One; 2021; 16(6):e0249499. PubMed ID: 34133415 [TBL] [Abstract][Full Text] [Related]
54. Longitudinal Profiling of Antibody Response in Patients With COVID-19 in a Tertiary Care Hospital in Beijing, China. Feng X; Yin J; Zhang J; Hu Y; Ouyang Y; Qiao S; Zhao H; Zhang T; Li X; Zhang L; Zhang J; Jin R; Feng Y; Su B Front Immunol; 2021; 12():614436. PubMed ID: 33790892 [TBL] [Abstract][Full Text] [Related]
55. Serum IgG anti-SARS-CoV-2 Binding Antibody Level Is Strongly Associated With IgA and Functional Antibody Levels in Adults Infected With SARS-CoV-2. Ye X; Angelo LS; Nicholson EG; Iwuchukwu OP; Cabral de Rezende W; Rajan A; Aideyan LO; McBride TJ; Bond N; Santarcangelo P; Rayford YJ; Ferlic-Stark L; Fragoso S; Momin Z; Liu H; Truong K; Lopez B; Conner ME; Rice AP; Kimata JT; Avadhanula V; Piedra PA Front Immunol; 2021; 12():693462. PubMed ID: 34691016 [TBL] [Abstract][Full Text] [Related]
56. Different Profiles of Antibodies and Cytokines Were Found Between Severe and Moderate COVID-19 Patients. Guo Y; Li T; Xia X; Su B; Li H; Feng Y; Han J; Wang X; Jia L; Bao Z; Li J; Liu Y; Li L Front Immunol; 2021; 12():723585. PubMed ID: 34489974 [TBL] [Abstract][Full Text] [Related]
57. Glycosylation and Serological Reactivity of an Expression-enhanced SARS-CoV-2 Viral Spike Mimetic. Chawla H; Jossi SE; Faustini SE; Samsudin F; Allen JD; Watanabe Y; Newby ML; Marcial-Juárez E; Lamerton RE; McLellan JS; Bond PJ; Richter AG; Cunningham AF; Crispin M J Mol Biol; 2022 Jan; 434(2):167332. PubMed ID: 34717971 [TBL] [Abstract][Full Text] [Related]
58. Evaluating SARS-CoV-2 spike and nucleocapsid proteins as targets for antibody detection in severe and mild COVID-19 cases using a Luminex bead-based assay. Mariën J; Ceulemans A; Michiels J; Heyndrickx L; Kerkhof K; Foque N; Widdowson MA; Mortgat L; Duysburgh E; Desombere I; Jansens H; Van Esbroeck M; Ariën KK J Virol Methods; 2021 Feb; 288():114025. PubMed ID: 33227340 [TBL] [Abstract][Full Text] [Related]
59. Testing IgG antibodies against the RBD of SARS-CoV-2 is sufficient and necessary for COVID-19 diagnosis. Indenbaum V; Koren R; Katz-Likvornik S; Yitzchaki M; Halpern O; Regev-Yochay G; Cohen C; Biber A; Feferman T; Cohen Saban N; Dhan R; Levin T; Gozlan Y; Weil M; Mor O; Mandelboim M; Sofer D; Mendelson E; Lustig Y PLoS One; 2020; 15(11):e0241164. PubMed ID: 33227020 [TBL] [Abstract][Full Text] [Related]
60. Kinetics of SARS-CoV-2 Specific and Neutralizing Antibodies over Seven Months after Symptom Onset in COVID-19 Patients. Zhu L; Xu X; Zhu B; Guo X; Xu K; Song C; Fu J; Yu H; Kong X; Peng J; Huang H; Zou X; Ding Y; Bao C; Zhu F; Hu Z; Wu M; Shen H Microbiol Spectr; 2021 Oct; 9(2):e0059021. PubMed ID: 34550000 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]